Cyanidin-3-O-glucoside as a Nutrigenomic Factor in Type 2 Diabetes and Its Prominent Impact on Health

Int J Mol Sci. 2023 Jun 5;24(11):9765. doi: 10.3390/ijms24119765.

Abstract

Type 2 diabetes (T2D) accounts for a global health problem. It is a complex disease as a result of the combination of environmental as well as genetic factors. Morbidity is still increasing across the world. One of the possibilities for the prevention and mitigation of the negative consequences of type 2 diabetes is a nutritional diet rich in bioactive compounds such as polyphenols. This review is focused on cyanidin-3-O-glucosidase (C3G), which belongs to the anthocyanins subclass, and its anti-diabetic properties. There are numerous pieces of evidence that C3G exerts positive effects on diabetic parameters, including in vitro and in vivo studies. It is involved in alleviating inflammation, reducing blood glucose, controlling postprandial hyperglycemia, and gene expression related to the development of T2D. C3G is one of the beneficial polyphenolic compounds that may help to overcome the public health problems associated with T2D.

Keywords: anthocyanins; bioactive compounds; civilization diseases; cyanidin-3-O-glucoside; nutrigenomics; polyphenols; type 2 diabetes.

Publication types

  • Review

MeSH terms

  • Anthocyanins / pharmacology
  • Anthocyanins / therapeutic use
  • Diabetes Mellitus, Type 2* / drug therapy
  • Diabetes Mellitus, Type 2* / genetics
  • Glucosides
  • Humans
  • Nutrigenomics

Substances

  • cyanidin
  • Anthocyanins
  • Glucosides

Grants and funding

This research received no external funding.